HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 73-84 of 1,979
Device study icon
CompletedNCT05179785

Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolarity

Official study title

Establishing the Effect of Electroencephalography (EEG)-Guided Theta Burst Stimulation on Reducing Mania/Hypomania-related Affect and Reward Driven Behavior in Bipolar Disorder

This study has finished and is no longer accepting participants.

In Pittsburgh
BipolarityDevice studyAges 18–35
Countries
United States
Sponsor
Mary Phillips, MD MD (Cantab)
Drug study icon
CompletedNCT00194129

Lithium and Divalproex for Comorbid Rapid Cycling Bipolarity and Substance Abuse Disorder

Official study title

A Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence

This study has finished and is no longer accepting participants.

In Cleveland
BipolarityMedication studyAges 16–65
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Drug study icon
CompletedNCT03257865

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes, Associated With Bipolarity type I

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States, Croatia, Ukraine
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Behavioral study icon
Not Yet RecruitingNCT07208721

The Key to Emotional Balance

Official study title

The Key to Emotional Balance: The Effect of a Positive Psychotherapy-Based Balance Model on Emotion Regulation, Recovery, and Life Purpose in Bipolar Disorder

This study isn't recruiting yet.

Location not clearly listed
BipolarityBehavioural studyAges 18–65
Countries
Sponsor
TC Erciyes University
Behavioral study icon
Active Not RecruitingNCT04815239

Early Intervention for Youth at High Risk for Bipolarity

Official study title

Early Intervention for Youth at High Risk for Bipolar Disorder

This study is no longer accepting new participants.

In Pittsburgh
BipolarityBehavioural studyAges 12–18
Countries
United States
Sponsor
University of Pittsburgh
Drug study icon
CompletedNCT00228059

Licarbazepine for manic episodes in bipolarity type I

What is this study about?

This study evaluated the safety of Licarbazepine for people with bipolarity.

This study has finished and is no longer accepting participants.

In Cerritos
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
Novartis
Drug study icon
CompletedNCT04819776

Iloperidone for Bipolarity

What is this study about?

Researchers compared Iloperidone and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States, Bulgaria, Poland
Sponsor
Vanda Pharmaceuticals
Drug study icon
CompletedNCT00139594

Open Label Extension Study of Licarbazepine in the Treatment of manic episodes of Bipolarity type I

What is this study about?

Researchers studied licarbazepine, tracking side effects to assess safety and tolerability in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including La Palma
BipolarityMedication studyAges 18–70
Countries
United States, Canada, Austria, + 10 others
Sponsor
Novartis

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.